Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major
Carla Casu(Children's Hospital of Philadelphia), Stefano Rivella(Children's Hospital of Philadelphia), Paraskevi Rea Oikonomidou(Children's Hospital of Philadelphia), Vania Lo Presti(University Medical Center Utrecht), Pedro Luiz Ramos(Novartis (Switzerland)), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Luca Melchiori(Adaptimmune (United Kingdom))
Cited by 33
Related Papers
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244
Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells
|Science|2018|159
Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression
|Journal of Clinical Investigation|2014|125
Investigating the magnetic susceptibility properties of fresh human blood for noninvasive oxygen saturation quantification
|Magnetic Resonance in Medicine|2011|115